Meaning
Formal corporate actions through which a governing body affirms, approves and validates previously unauthorized or procedurally deficient transactions define this curative governance procedure. An entity executing retrospective ratification treats an ultra vires act, defective share issuance or unapproved director deal as if it carried valid prior authorization. The mechanism operates retroactively, curing internal defects from the precise date on which the original transaction was executed.
It applies across internal governance decisions, employment agreements and financial commitments executed by agents lacking explicit authority. The principle cannot cure outright illegality, fraudulent conversions or transactions that infringe third-party statutory rights established prior to ratification.
Curative Resolutions
Execution of a ratifying measure requires the present, fully constituted governing authority to assemble, inspect the defective event and pass unambiguous resolutions. The written record must state the defect, verify full knowledge of the procedural breach and affirm the legal commitment. Deficiencies arising from conflicted directors can be healed only if independent shareholders or disinterested board members vote to approve the action.
Defective equity issuances often require court-sanctioned statutory ratification filings to repair the capitalization table. The procedural documentation creates a clean, continuous chain of corporate authorization.
Evidentiary Baseline
Validating past unauthorized behavior requires comprehensive disclosure documents detailing exactly what occurred, who executed the arrangement and what benefits accrued to the business. Contemporaneous contracts signed by the unauthorized agent must be appended to the ratifying board minutes. Personal recollections by directors that they always supported the deal fail to cure defects without recorded resolutions.
Complete transparency protects the ratification against downstream challenges brought by incoming investors or dissenting shareholders. The corporate minute book serves as the exclusive paper trail proving the cure took place.
Commercial Validity
Successful execution of the process insulates unauthorized deals against subsequent internal nullification or claims of agent overreach. The act discharges the performing agent from personal liability toward the enterprise for acting beyond their granted mandate. Third parties holding contracts with the enterprise gain enforceable rights identical to agreements authorized through normal advance voting.
The cost of failing to ratify defective corporate actions manifests during financing diligence, where unhealed share issuances halt capital acquisitions. A completed ratification binds the enterprise irrevocably to the historical transaction.
